About: OBJECTIVES: Critical cases of coronavirus disease 2019 (COVID‐19) are associated with a high risk of mortality. It remains unclear why patients with the same critical condition have different outcomes. We aimed to explore relevant factors that may affect the prognosis of critical COVID‐19 patients. METHODS: Six critical COVID‐19 inpatients were included in our study. The 6 patients were divided into two groups based on whether they had a good or poor prognosis. We collected peripheral blood samples at admission and the time point of exacerbation to compare differences in the phenotypes and functions of major populations of immune cells between the groups. RESULTS: On admission, compared to patients with poor prognoses, those with good prognoses had significantly higher counts of monocytes (p < 0.05), macrophages (p < 0.05), higher frequency of CD3(+)CD4(+)CD45RO(+)CXCR3(+) subsets (p < 0.05), higher frequency of CD14(+)CD11C(+)HLA‐DR(+) subset of dendritic cells (DCs) (p < 0.05), and a lower count of neutrophils (p < 0.05). At the time point of exacerbation, the proportions of naïve CD4(+) T cells (p < 0.05), Tregs, and Th2 cells in the poor prognosis group were relatively higher than those in the good prognosis group, and CD4(+) memory T cells were relatively lower (p < 0.05). CONCLUSION: According to our results, the poor prognosis group showed a worse immune response than the good prognosis group at the time of admission and at exacerbation. Dysregulation of the immune response affects the outcome of critical COVID‐19 patients. This article is protected by copyright. All rights reserved.   Goto Sponge  NotDistinct  Permalink

An Entity of Type : fabio:Abstract, within Data Space : covidontheweb.inria.fr associated with source document(s)

AttributesValues
type
value
  • OBJECTIVES: Critical cases of coronavirus disease 2019 (COVID‐19) are associated with a high risk of mortality. It remains unclear why patients with the same critical condition have different outcomes. We aimed to explore relevant factors that may affect the prognosis of critical COVID‐19 patients. METHODS: Six critical COVID‐19 inpatients were included in our study. The 6 patients were divided into two groups based on whether they had a good or poor prognosis. We collected peripheral blood samples at admission and the time point of exacerbation to compare differences in the phenotypes and functions of major populations of immune cells between the groups. RESULTS: On admission, compared to patients with poor prognoses, those with good prognoses had significantly higher counts of monocytes (p < 0.05), macrophages (p < 0.05), higher frequency of CD3(+)CD4(+)CD45RO(+)CXCR3(+) subsets (p < 0.05), higher frequency of CD14(+)CD11C(+)HLA‐DR(+) subset of dendritic cells (DCs) (p < 0.05), and a lower count of neutrophils (p < 0.05). At the time point of exacerbation, the proportions of naïve CD4(+) T cells (p < 0.05), Tregs, and Th2 cells in the poor prognosis group were relatively higher than those in the good prognosis group, and CD4(+) memory T cells were relatively lower (p < 0.05). CONCLUSION: According to our results, the poor prognosis group showed a worse immune response than the good prognosis group at the time of admission and at exacerbation. Dysregulation of the immune response affects the outcome of critical COVID‐19 patients. This article is protected by copyright. All rights reserved.
part of
is abstract of
is hasSource of
Faceted Search & Find service v1.13.91 as of Mar 24 2020


Alternative Linked Data Documents: Sponger | ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software